Cargando…
FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy
OBJECTIVE: Inflammatory cardiomyopathy is characterised by inflammatory infiltrates leading to cardiac injury, left ventricular (LV) dilatation and reduced LV ejection fraction (LVEF). Several viral pathogens and autoimmune phenomena may cause cardiac inflammation. The effects of the gain of functio...
Autores principales: | Makrutzki-Zlotek, Kamila, Escher, Felicitas, Karadeniz, Zehra, Aleshcheva, Ganna, Pietsch, Heiko, Küchler, Konstanze, Schultheiss, Heinz-Peter, Heidecker, Bettina, Poller, Wolfgang, Landmesser, Ulf, Scheibenbogen, Carmen, Thevathasan, Tharusan, Skurk, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314059/ https://www.ncbi.nlm.nih.gov/pubmed/36702542 http://dx.doi.org/10.1136/heartjnl-2022-321732 |
Ejemplares similares
-
Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up
por: Berg, Jan, et al.
Publicado: (2019) -
Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020) -
Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009) -
Prospective development and validation of a model to predict heart failure hospitalisation
por: Cubbon, R M, et al.
Publicado: (2014) -
Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)